PPARGC1B and metastatic malignant neoplasm in the lymph nodes: Results from human breast cancer tissues indicated that abnormal expression of PGC-1β was closely related to the clinicopathological characteristics of patients, such as Lymph node metastasis (P = 0.026) and Progesterone receptor (P = 0.026) (Table 2).